The National Human Genome Research Institute (NHGRI) has launched an online tool to help educators teach the next generation of nurses and physician assistants about genetics and genomics, which are paving the way for more individualized approaches to detect, treat and prevent many diseases. The Genetics/Genomics Competency Center (G2C2, www.g-2-c-2.org) is a free, Web-based collection of materials on genetics and genomics designed for educators who train nurses and physician assistants.
IBM’s World Community Grid and its volunteers have helped the Scripps Research Institute discover two new compounds that prove the existence of new binding sites on an enzyme, the HIV protease, used by HIV to create new, infectious viral particles. The results were published in the March issue of Chemical Biology and Drug Design. IBM’s World Community Grid and its volunteers help Scripps run millions of computations to evaluate the potential interactions between compounds and mutant viral proteins. Over the last 5 years, World Community Grid has provided Scripps researchers with 107,000 years of computation time.
Lilly Goes Biotech
Eli Lilly and Covance have added a biotech element to their 10-year research agreement that started in 2008. Covance will begin early-stage testing of biotech drugs for Eli Lilly at a new biotech facility in Greenfield, Indiana. Covance bought the site from Lilly in 2008. Covance conducted 3,800 studies for Lilly last year ranging from discovery to work to late-stage clinical testing. Lilly plans to shift 17 employees to Covance to work in the new Greenfield facility.
This article also appeared in the March-April 2010 issue of Bio-IT World Magazine.
Subscriptions are free for qualifying individuals. Apply today.